These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14644513)

  • 41. Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo.
    Tatsuta T; Satoh T; Sugawara S; Hara A; Hosono M
    PLoS One; 2018; 13(1):e0190653. PubMed ID: 29298350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors.
    Song S; Yu B; Wei Y; Wientjes MG; Au JL
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6058-65. PubMed ID: 15447990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of diffuse peritoneal malignant mesothelioma--intraabdominal administration of cisplatin is useful for diminishing ascites].
    Noguchi T; Kawamura M; Kawamura T; Shimamura T; Sasaki K; Hosono T; Sato R; Murakami K
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1975-8. PubMed ID: 20948267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Inhibitory effects of suramin on growth of transplanted lung adencarcinoma in mice and its mechanisms].
    He JB; Yi GZ; Yang K; Xiang Z; Xie MF; Zhang P
    Ai Zheng; 2008 Apr; 27(4):359-63. PubMed ID: 18423120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts.
    Takenouchi M; Hirai S; Sakuragi N; Yagita H; Hamada H; Kato K
    Clin Cancer Res; 2011 May; 17(9):2819-29. PubMed ID: 21357681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravital microscopic characterization of suramin effects in an orthotopic immunocompetent rat model of pancreatic cancer.
    Hotz B; Buhr HJ; Hotz HG
    J Gastrointest Surg; 2008 May; 12(5):900-6. PubMed ID: 18320288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.
    Van TT; Hanibuchi M; Goto H; Kuramoto T; Yukishige S; Kakiuchi S; Sato S; Sakaguchi S; Dat le T; Nishioka Y; Akiyama S; Sone S
    Respirology; 2012 Aug; 17(6):984-90. PubMed ID: 22574723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
    Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
    Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.
    Gan Y; Lu J; Yeung BZ; Cottage CT; Wientjes MG; Au JL
    AAPS J; 2015 Jan; 17(1):268-76. PubMed ID: 25425294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma.
    Spanò V; Pennati M; Parrino B; Carbone A; Montalbano A; Cilibrasi V; Zuco V; Lopergolo A; Cominetti D; Diana P; Cirrincione G; Barraja P; Zaffaroni N
    J Med Chem; 2016 Aug; 59(15):7223-38. PubMed ID: 27428868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
    Arrieta O; Guevara P; Reyes S; Ortiz A; Rembao D; Sotelo J
    Eur J Cancer; 1998 Dec; 34(13):2101-6. PubMed ID: 10070318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peritoneal mesothelioma: current status and future directions.
    Chua TC; Chong CH; Morris DL
    Surg Oncol Clin N Am; 2012 Oct; 21(4):635-43. PubMed ID: 23021721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
    Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
    Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
    Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
    J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice.
    Lukacs KV; Porter CD; Pardo OE; Oakley RE; Steel RM; Judd DV; Browning JE; Geddes DM; Alton EW
    Hum Gene Ther; 1999 Sep; 10(14):2373-9. PubMed ID: 10515457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suramin inhibits glioma cell proliferation in vitro and in the brain.
    Takano S; Gately S; Engelhard H; Tsanaclis AM; Brem S
    J Neurooncol; 1994; 21(3):189-201. PubMed ID: 7699415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
    Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V
    Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial.
    Motzer RJ; Dmitrovsky E; Miller WH; Tong WP; Bajorin DF; Scher HI; Bost GJ
    Cancer; 1993 Dec; 72(11):3313-7. PubMed ID: 8242558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.